BRIEF-Vanda Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results
BRIEF-Vanda Pharmaceuticals Reports Fourth Quarter And Full Year 2020 Financial Results
* VANDA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* VANDA PHARMACEUTICALS INC - Q4 2020 TOTAL REVENUES GREW TO $67.7 MILLION, AN 11% INCREASE COMPARED TO Q4 2019
* VANDA PHARMACEUTICALS INC - END OF YEAR 2021 CASH EXPECTED TO BE GREATER THAN $400 MILLION
* VANDA PHARMACEUTICALS INC SEES 2021 TOTAL REVENUES $270 TO $300 MILLION
* VANDA PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.15
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
Feb 10 (Reuters) - Vanda Pharmaceuticals Inc :
* VANDA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* VANDA PHARMACEUTICALS INC - Q4 2020 TOTAL REVENUES GREW TO $67.7 MILLION, AN 11% INCREASE COMPARED TO Q4 2019
* VANDA PHARMACEUTICALS INC - END OF YEAR 2021 CASH EXPECTED TO BE GREATER THAN $400 MILLION
* VANDA PHARMACEUTICALS INC SEES 2021 TOTAL REVENUES $270 TO $300 MILLION
* VANDA PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.15
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透2月10日电-万达制药(Vanda PharmPharmticals Inc)：*Vanda PharmPharmticals报告2020年第四季度和全年财务业绩*Vanda PharmPharmticals Inc-2020年第四季度总收入增长至6770万美元，比2019年第四季度增长11%*Vanda PharmPharmticals Inc.-2021年底现金预计将超过4亿美元*Vanda PharmPharmticals Inc.预计2021年总收入为2.7亿至3亿美元*Vanda PharmPharmticals Inc Qtrly每股收益0.15美元Eikon的源文本：进一步的公司报道：(Reurs.Briefs@thomsonreurs.com；)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧